tiprankstipranks
AbbVie (GB:0QCV)
LSE:0QCV

AbbVie (0QCV) Technical Analysis

7 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is 1.61, suggesting AbbVie is a Sell.
AbbVie’s (0QCV) 20-Day exponential moving average is 168.39, while AbbVie’s (0QCV) share price is $171.435, making it a Buy.
AbbVie’s (0QCV) 50-Day exponential moving average is 166.55, while AbbVie’s (0QCV) share price is $171.435, making it a Buy.

AbbVie (0QCV) Pivot Points

Jul 22, 2024, 08:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
167.33
169.97
171.29
173.93
175.25
177.89
179.21
Fibonacci
169.97
171.48
172.42
173.93
175.44
176.38
177.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

Jul 22, 2024, 08:15 PM
Period
Simple
Exponential
MA5
171.08Buy
171.16Buy
MA10
169.07Buy
169.79Buy
MA20
168.07Buy
168.39Buy
MA50
164.79Buy
166.55Buy
MA100
167.14Buy
164.93Buy
MA200
158.93Buy
158.25Buy
AbbVie’s (0QCV) 10-Day exponential moving average is 169.79, while AbbVie’s (0QCV) share price is $171.435, making it a Buy.
AbbVie’s (0QCV) 100-Day exponential moving average is 164.93, while AbbVie’s (0QCV) share price is $171.435, making it a Buy.
AbbVie’s (0QCV) stock price is $171.435 and AbbVie’s (0QCV) 50-day simple moving average is 164.79, creating a Buy signal.
AbbVie’s (0QCV) stock price is $171.435 and AbbVie’s (0QCV) 100-day simple moving average is 167.14, creating a Buy signal.
AbbVie’s (0QCV) stock price is $171.435 and AbbVie’s (0QCV) 200-day simple moving average is 158.93, creating a Buy signal.

AbbVie (0QCV) Technical Indicators

Jul 22, 2024, 08:15 PM
Name
Value
Implied Action
RSI (14)
57.72
Neutral
STOCH (9,6)
70.90
Neutral
STOCHRSI (14)
73.60
Neutral
MACD (12,26)
1.61
Sell
ADX (14)
20.40
Neutral
Williams %R
-39.62
Buy
CCI (14)
86.53
Neutral
ATR (14)
3.47
-
Ultimate Oscillator
39.05
Neutral
ROC
1.79
Buy
AbbVie’s (0QCV) Relative Strength Index (RSI) is 57.72, creating a Neutral signal.
AbbVie’s (0QCV) Trend Strength Indicator (ADX) is 20.40, creating a Neutral signal.
AbbVie’s (0QCV) Commodity Channel Index (CCI) is 86.53, creating a Neutral signal.
AbbVie’s (0QCV) Price Rate of Change (ROC) is 1.79, creating a Buy signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Strong Buy.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 57.72, which suggests 0QCV is a Neutral.
      What is 0QCV’s MACD?
      0QCV’s MACD is 1.61, which suggests 0QCV is a Sell.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 171.08, which suggests 0QCV is a Buy.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 168.07, which suggests 0QCV is a Buy.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 164.79, which suggests 0QCV is a Buy.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 158.93, which suggests 0QCV is a Buy.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is -39.62, which suggests 0QCV is a Buy.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is 86.53, which suggests 0QCV is a Neutral.
                    What is the share price of AbbVie?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis